Search research articles
Contact Us
Filters
Showing results (1-10 of 354) with videos related to
Page
of 36
Sort By:
World Journal of Urology
|
July 2, 2016
The rationale and the role of lymph node dissection in renal cell carcinoma
Umberto Capitanio, Bradley C Leibovich
Current Urology Reports
|
January 23, 2003
Should there be a size limit for elective nephron-sparing surgery?
Kent G Krejci, Bradley C Leibovich
Mayo Clinic Proceedings
|
July 13, 2005
Adenocarcinoma of the prostate: epidemiological trends, screening, diagnosis, and surgical management of localized disease
Jonathan C Routh, Bradley C Leibovich
Seminars in Oncology
|
October 19, 2006
Surgical management of renal cell carcinoma
Bradley C Leibovich, Michael L Blute
Expert Review of Anticancer Therapy
|
December 13, 2005
Exisulind in the treatment of prostate cancer
W Scott Webster, Bradley C Leibovich
The Urologic Clinics of North America
|
November 11, 2008
Lymph node dissection in the management of renal cell carcinoma
Bradley C Leibovich, Michael L Blute
Therapeutic Advances in Urology
|
October 8, 2015
Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma
Sarah P Psutka, Bradley C Leibovich
European Urology Focus
|
February 20, 2019
Partial Versus Radical Nephrectomy for the Clinical T1a Renal Mass
Boris Gershman, Bradley C Leibovich, Simon P Kim
Current Urology Reports
|
January 24, 2007
Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma
Matthew K Tollefson, Naoki Takahashi, Bradley C Leibovich
AJR. American Journal of Roentgenology
|
November 25, 2010
Adrenal hematoma after nephrectomy
Kewalee Sasiwimonphan, Naoki Takahashi, Bradley C Leibovich, et al.
Page
of 36
Search research articles
Search
Showing results (1-10 of 354) with videos related to
Sort By:
Page
of 36
World Journal of Urology
|
July 2, 2016
The rationale and the role of lymph node dissection in renal cell carcinoma
Umberto Capitanio, Bradley C Leibovich
Current Urology Reports
|
January 23, 2003
Should there be a size limit for elective nephron-sparing surgery?
Kent G Krejci, Bradley C Leibovich
Mayo Clinic Proceedings
|
July 13, 2005
Adenocarcinoma of the prostate: epidemiological trends, screening, diagnosis, and surgical management of localized disease
Jonathan C Routh, Bradley C Leibovich
Seminars in Oncology
|
October 19, 2006
Surgical management of renal cell carcinoma
Bradley C Leibovich, Michael L Blute
Expert Review of Anticancer Therapy
|
December 13, 2005
Exisulind in the treatment of prostate cancer
W Scott Webster, Bradley C Leibovich
The Urologic Clinics of North America
|
November 11, 2008
Lymph node dissection in the management of renal cell carcinoma
Bradley C Leibovich, Michael L Blute
Therapeutic Advances in Urology
|
October 8, 2015
Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma
Sarah P Psutka, Bradley C Leibovich
European Urology Focus
|
February 20, 2019
Partial Versus Radical Nephrectomy for the Clinical T1a Renal Mass
Boris Gershman, Bradley C Leibovich, Simon P Kim
Current Urology Reports
|
January 24, 2007
Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma
Matthew K Tollefson, Naoki Takahashi, Bradley C Leibovich
AJR. American Journal of Roentgenology
|
November 25, 2010
Adrenal hematoma after nephrectomy
Kewalee Sasiwimonphan, Naoki Takahashi, Bradley C Leibovich, et al.
Page
of 36